Life sciences · Journal article
Emerging Microbes & Infections · June 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a molecular surveillance report of a newly identified H9N2 avian influenza clade (Clade 4.6.20) circulating in Laos in 2024, characterized by genetic divergence (4.0% distance from nearest clade) and possession of mutations associated with human-type receptor binding (HA-L226) and innate immunity escape (NP-N52). The clinical and epidemiologic significance of these findings remains undefined; the study provides early warning for surveillance and vaccine development but does not establish elevated zoonotic risk or pandemic potential.
Prospective surveillance with molecular characterization and phylogenetic analysis. Poultry sampled from live poultry markets and backyard farms in Vientiane, Luang Prabang, and Xieng Khouang provinces, Laos. Sampled birds comprised 124 chickens, 155 ducks, 30 pigeons, and 2 turkeys from apparently healthy animals.. Intervention: None; observational surveillance study. Compared with: None; descriptive characterization with phylogenetic comparison to previously described H9N2 clades. n = 622. Three provinces in Laos: Vientiane, Luang Prabang, and Xieng Khouang.
52 H9N2 strains identified from 68 AIV-positive samples collected May–June 2024 from poultry in three Laotian provinces Novel HA gene clade designated Clade 4.6.20 exhibiting 4.0% genetic distance from nearest Clade 4.6.14 All Clade 4.6.20 viruses possessed HA-L226 and NP-N52 mutations associated with human-type receptor binding and MxA-related innate immunity escape
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians and public health professionals should note this as part of global H9N2 surveillance alerting to emerging genetic diversity in a migratory bird flyway region. The presence of receptor-binding and immunity-escape mutations warrants continued monitoring but does not yet establish direct zoonotic or pandemic risk; vaccine strain updates and surveillance intensification are recommended precautions.
Novel H9N2 clade identified through surveillance in a single region with concerning mutations, but lacks clinical outcome data, animal models, or human epidemiologic evidence of enhanced transmissibility or virulence.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians and public health professionals should note this as part of global H9N2 surveillance alerting to emerging genetic diversity in a migratory bird flyway region. The presence of receptor-binding and immunity-escape mutations warrants continued monitoring but does not yet establish direct zoonotic or pandemic risk; vaccine strain updates and surveillance intensification are recommended precautions.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
In 2024, we identified and sequenced 52 avian influenza A (H9N2) virus strains in Laos. Using the established H9N2 genomic classification system, a novel HA gene clade of the A/chicken/Beijing/1/94-like (BJ/94-like) lineage, designated Clade 4.6.20, was identified. This new clade is phylogenetically distinct from the previously described clades, and the representative strains in this new Clade 4.6.20 presented a low cross reactivity to the antisera of other clades, suggesting antigenic drift of the viruses between the new Clade 4.6.20, and other clades in the dominant lineage of Clade 4.6. In addition, all the newly identified viruses in Clade 4.6.20 possessed HA-L226 and NP-N52 mutations, which are associated with human-type receptor binding and human MxA-related innate immunity escape, respectively. Our findings underscore the necessity of global surveillance network and cooperation to monitor the evolution of AIVs, update vaccine seed strains, and develop new vaccines with high effectiveness against H9N2 AIVs circulating globally, which threaten poultry and human health.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.